Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123133774> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2123133774 endingPage "511" @default.
- W2123133774 startingPage "501" @default.
- W2123133774 abstract "A series of in vivo, ex vivo and in vitro studies were conducted to determine the pharmacokinetic and pharmacodynamic properties of cefovecin, a new injectable cephalosporin, in dogs. Absolute bioavailability was determined in a two-phase cross-over study in dogs receiving 8 mg/kg bodyweight (b.w.) of cefovecin by either subcutaneous (s.c.) or intravenous (i.v.) route. After s.c. administration, cefovecin was fully bioavailable (100%), the mean maximum plasma concentration (Cmax) was 121 microg/mL and the mean apparent elimination half-life (t1/2) was 133 h. Clearance was measured to be 0.76 mL/h/kg after i.v. dosing. The concentration of cefovecin in urine measured 14 days after s.c. administration was 2.9 microg/mL. Plasma protein binding was determined by equilibrium dialysis; over concentrations ranging from 10 to 100 microg/mL (i.e. up to the approximate Cmax following an 8 mg/kg dose), protein binding of 98.7% to 96.0% was observed, however, binding was lower at higher concentrations. Total and free concentrations of cefovecin were determined in plasma, transudate and exudate collected from dogs previously implanted subcutaneously with tissue cages. Mean peak concentrations of free cefovecin were almost three times higher in transudate than in plasma and remained above 0.25 microg/mL for 19 days. The ex vivo antibacterial killing activity (vs. Staphylococcus intermedius, MIC 0.25 microg/mL) was measured in serum, transudate and exudate collected from dogs which had received 8 mg/kg b.w. of cefovecin subcutaneously. Transudate exhibited higher antimicrobial killing activity than serum. Activity in serum and exudate exhibited a mean reduction in bacterial counts of S. intermedius of at least three log units up to 72 h postadministration. Bactericidal activity (>3 log10 reduction of bacterial counts) was observed in transudate up to 12 days postadministration. The slow elimination and long lasting ex vivo antibacterial killing activity following administration of cefovecin are desirable pharmacokinetic and pharmacodynamic attributes for an antimicrobial drug with 14-day dosing intervals." @default.
- W2123133774 created "2016-06-24" @default.
- W2123133774 creator A5024588664 @default.
- W2123133774 creator A5056887296 @default.
- W2123133774 creator A5075606120 @default.
- W2123133774 date "2006-11-02" @default.
- W2123133774 modified "2023-10-18" @default.
- W2123133774 title "Pharmacokinetics and pharmacodynamics of cefovecin in dogs" @default.
- W2123133774 cites W1960433349 @default.
- W2123133774 cites W1966267502 @default.
- W2123133774 cites W1969128660 @default.
- W2123133774 cites W1971317116 @default.
- W2123133774 cites W1992442326 @default.
- W2123133774 cites W1994471989 @default.
- W2123133774 cites W2010045322 @default.
- W2123133774 cites W2020616747 @default.
- W2123133774 cites W2037198044 @default.
- W2123133774 cites W2059989328 @default.
- W2123133774 cites W2067034394 @default.
- W2123133774 cites W2081349106 @default.
- W2123133774 cites W2091351783 @default.
- W2123133774 cites W2108310800 @default.
- W2123133774 cites W2113717321 @default.
- W2123133774 cites W2143478635 @default.
- W2123133774 cites W2159252586 @default.
- W2123133774 cites W2166840599 @default.
- W2123133774 doi "https://doi.org/10.1111/j.1365-2885.2006.00801.x" @default.
- W2123133774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17083454" @default.
- W2123133774 hasPublicationYear "2006" @default.
- W2123133774 type Work @default.
- W2123133774 sameAs 2123133774 @default.
- W2123133774 citedByCount "74" @default.
- W2123133774 countsByYear W21231337742012 @default.
- W2123133774 countsByYear W21231337742013 @default.
- W2123133774 countsByYear W21231337742014 @default.
- W2123133774 countsByYear W21231337742015 @default.
- W2123133774 countsByYear W21231337742016 @default.
- W2123133774 countsByYear W21231337742017 @default.
- W2123133774 countsByYear W21231337742018 @default.
- W2123133774 countsByYear W21231337742019 @default.
- W2123133774 countsByYear W21231337742020 @default.
- W2123133774 countsByYear W21231337742021 @default.
- W2123133774 countsByYear W21231337742022 @default.
- W2123133774 countsByYear W21231337742023 @default.
- W2123133774 crossrefType "journal-article" @default.
- W2123133774 hasAuthorship W2123133774A5024588664 @default.
- W2123133774 hasAuthorship W2123133774A5056887296 @default.
- W2123133774 hasAuthorship W2123133774A5075606120 @default.
- W2123133774 hasConcept C111113717 @default.
- W2123133774 hasConcept C112705442 @default.
- W2123133774 hasConcept C126322002 @default.
- W2123133774 hasConcept C150903083 @default.
- W2123133774 hasConcept C181389837 @default.
- W2123133774 hasConcept C185592680 @default.
- W2123133774 hasConcept C207001950 @default.
- W2123133774 hasConcept C22979827 @default.
- W2123133774 hasConcept C2777288759 @default.
- W2123133774 hasConcept C2779634585 @default.
- W2123133774 hasConcept C2781408492 @default.
- W2123133774 hasConcept C2993292583 @default.
- W2123133774 hasConcept C71924100 @default.
- W2123133774 hasConcept C86803240 @default.
- W2123133774 hasConcept C98274493 @default.
- W2123133774 hasConceptScore W2123133774C111113717 @default.
- W2123133774 hasConceptScore W2123133774C112705442 @default.
- W2123133774 hasConceptScore W2123133774C126322002 @default.
- W2123133774 hasConceptScore W2123133774C150903083 @default.
- W2123133774 hasConceptScore W2123133774C181389837 @default.
- W2123133774 hasConceptScore W2123133774C185592680 @default.
- W2123133774 hasConceptScore W2123133774C207001950 @default.
- W2123133774 hasConceptScore W2123133774C22979827 @default.
- W2123133774 hasConceptScore W2123133774C2777288759 @default.
- W2123133774 hasConceptScore W2123133774C2779634585 @default.
- W2123133774 hasConceptScore W2123133774C2781408492 @default.
- W2123133774 hasConceptScore W2123133774C2993292583 @default.
- W2123133774 hasConceptScore W2123133774C71924100 @default.
- W2123133774 hasConceptScore W2123133774C86803240 @default.
- W2123133774 hasConceptScore W2123133774C98274493 @default.
- W2123133774 hasIssue "6" @default.
- W2123133774 hasLocation W21231337741 @default.
- W2123133774 hasLocation W21231337742 @default.
- W2123133774 hasOpenAccess W2123133774 @default.
- W2123133774 hasPrimaryLocation W21231337741 @default.
- W2123133774 hasRelatedWork W2091436125 @default.
- W2123133774 hasRelatedWork W2368571621 @default.
- W2123133774 hasRelatedWork W2401279245 @default.
- W2123133774 hasRelatedWork W2425400028 @default.
- W2123133774 hasRelatedWork W2594405597 @default.
- W2123133774 hasRelatedWork W2981077837 @default.
- W2123133774 hasRelatedWork W2998000519 @default.
- W2123133774 hasRelatedWork W3202850272 @default.
- W2123133774 hasRelatedWork W3203131599 @default.
- W2123133774 hasRelatedWork W4225564610 @default.
- W2123133774 hasVolume "29" @default.
- W2123133774 isParatext "false" @default.
- W2123133774 isRetracted "false" @default.
- W2123133774 magId "2123133774" @default.
- W2123133774 workType "article" @default.